-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M4vxVobsP9E1ReJ1WnySthr+P75wp2baV/fes+j160QwKR2eE5tr2VkwTQA2LHOQ ZEcjubP0LFWAKOeeVKcUIw== 0000728889-06-000460.txt : 20060606 0000728889-06-000460.hdr.sgml : 20060606 20060606122607 ACCESSION NUMBER: 0000728889-06-000460 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060606 DATE AS OF CHANGE: 20060606 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ATHEROGENICS INC CENTRAL INDEX KEY: 0001107601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582108232 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60563 FILM NUMBER: 06888558 BUSINESS ADDRESS: STREET 1: 8995 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 6783362500 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER FUNDS INC CENTRAL INDEX KEY: 0000728889 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 000000000 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER MANAGEMENT CORP DATE OF NAME CHANGE: 19940131 SC 13G 1 form13g.htm INITIAL FORM 13G Atherogenics Inc. 
                                      UNITED STATES
                            SECURITIES AND EXCHANGE COMMISSION
                                  Washington, D.C. 20549


                                       SCHEDULE 13G
                        Under the Securities Exchange Act of 1934
                                    (Amendment No. )*

                                   Atherogenics Inc.

                                    (Name of Issuer)

                                      Common Stock

                             (Title of Class of Securities)

                                       047439104

                                     (CUSIP Number)
                                       05/31/2006

                (Date of Event Which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[X]      Rule 13d-1(b)
[  ]     Rule 13d-1(c)
[  ]     Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial
filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in
a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act (however, see the Notes).












 ------------------------------------------------------------------------------------------
  CUSIP No.: 047439104

 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       1.       Names of Reporting Persons
                IRS Identification No:

                OppenheimerFunds, Inc.
                IRS No. 13-2527171
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       2.        Check the Appropriate Box if a Member of a Group (See Instructions):
                 Joint Filing

 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       3.       SEC Use Only
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       4.       Citizenship or Place of Organization:
                Colorado
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------
   Number of
     Shares     5.    Sole Voting Power:
  Beneficially       0
    Owned by
      Each
   Reporting
  Person With
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

                6.    Shared Voting Power:
                     5,378,500
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

                7.    Sole Dispositive Power:
                     0
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

                8.    Shared Dispositive Power:
                     5,378,500
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       9.       Aggregate Amount Beneficially Owned by Each Reporting Person:
                5,378,500 (beneficial ownership disclaimed pursuant to Rule 13d-4 of the
                Exchange Act of 1934)
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

      10.       Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
                Instructions)
                [  ]
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

      11.       Percent of Class Represented by Amount in Row (9):
                13.64%
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

      12.       Type of Reporting Person (See Instructions):
                IA
 ------------------------------------------------------------------------------------------












 ------------------------------------------------------------------------------------------
  CUSIP No.: 047439104

 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       1.       Names of Reporting Persons
                IRS Identification No: 13-2649093

                Oppenheimer Global Fund
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       2.        Check the Appropriate Box if a Member of a Group (See Instructions):
                 Joint Filing

 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       3.       SEC Use Only
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       4.       Citizenship or Place of Organization:
                Massachusetts
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------
   Number of
     Shares     5.      Sole Voting Power:
  Beneficially       0
    Owned by
      Each
   Reporting
  Person With
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

                6.       Shared Voting Power:
                     2,000,000
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

                7.    Sole Dispositive Power:
                     0
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

                8.    Shared Dispositive Power:
                     2,000,000
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

       9.       Aggregate Amount Beneficially Owned by Each Reporting Person:
                2,000,000
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

      10.       Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
                Instructions)
                [  ]
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

      11.       Percent of Class Represented by Amount in Row (9):
                5.07%
 ------------------------------------------------------------------------------------------
 ------------------------------------------------------------------------------------------

      12.       Type of Reporting Person (See Instructions):
                IV
 ------------------------------------------------------------------------------------------


 ---------------------------------------------------------------------------------------
 Item:
 ---------------------------------------------------------------------------------------






 ---------------------------------------------------------------------------------------

     1(a)     Name of Issuer:
              Atherogenics Inc.
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     1(b)     Address of Issuer's Principal Executive Offices:
              8995 Westside Parkway
              Alpharetta, GA 30004
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     2(a)     Name of Person Filing:
              (i)   OppenheimerFunds, Inc.
              (ii)  Oppenheimer Global Fund
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     2(b)     Address of Principal Business Office or, if none, Residence:
              (i)   Two World Financial Center
                 225 Liberty Street, 11th Floor
                    New York, NY 10281-1008
              (ii)  6803 S. Tucson Way
                    Centennial, CO  80112
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     2(c)     Citizenship:
              (i)  Colorado
              (ii) Massachusetts
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     2(d)     Title of Class of Securities:
              Common Stock
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     2(e)     CUSIP Number:
              047439104
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      3       OppenheimerFunds, Inc. is an investment adviser in accordance with Rule
              13d-1(b)(1)(ii)(E).
              Oppenheimer Global Fund is an investment company registered under
              section 8 of the Investment Company Act of 1940.
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     4(a)     Amount beneficially owned:
              (i)  5,378,500 (beneficial ownership disclaimed pursuant to Rule 13d-4
              of the Exchange Act of 1934) (includes ownership reported in 4(a)(ii)
              below).
              (ii) 2,000,000
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     4(b)     Percent of class:
              (i)  13.64%  (includes ownership reported in 4(b)(ii) below)
              (ii) 5.07%
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      4(c)    Number of shares as to which the person has:

         (i)  Sole power to vote or to direct the vote:
              (a)   0
              (b)   0
         (ii) Shared power to vote or to direct the vote:
              (a)   5,378,500
              (b)   2,000,000
       (iii)  Sole power to dispose or to direct the disposition of:
              (a)   0
              (b)   0
        (iv)  Shared power to dispose or to direct the disposition of:
              (a)   5,378,500
              (b)     2,000,000
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      5.      Ownership of Five Percent or Less of a Class: [  ]
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      6.      Ownership of More than Five Percent on Behalf of Another Person:

 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      7.      Identification and Classification of the Subsidiary Which Acquired the
              Security Being Reported on By the Parent Holding Company:
              N/A
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      8.      Identification and Classification of Members of the Group:
              N/A
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

      9.      Notice of Dissolution of Group:
              N/A
 ---------------------------------------------------------------------------------------
 ---------------------------------------------------------------------------------------

     10.      Certification:
              By signing below I certify that, to the best of my knowledge and belief,
              the securities referred to above were acquired and are held in the
              ordinary course of business and were not acquired and are not held for
              the purpose of or with the effect of changing or influencing the control
              of the issuer of the securities and were not acquired and are not held
              in connection with or as a participant in any transaction having that
              purpose or effect.
 ---------------------------------------------------------------------------------------


                                        SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.

                                                             06/06/2006
                                                            Date

                                                      /s/ Mark S. Vandehey
                                                            Signature

                                                Mark S. Vandehey, Senior Vice President
and
                                                Chief Compliance Officer;
                                                OppenheimerFunds, Inc.
                                                            Name/Title
atherogenics initial 13g(053106).rtf
-----END PRIVACY-ENHANCED MESSAGE-----